<?xml version="1.0" ?> <rss xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="2.0"><channel><title>Pharmaceutical Processing - Articles</title><link>http://www.pharmpro.com/rss.aspx?id=106</link><description>Articles</description><item><title>How To Read A Regulator Flow Curve</title><link>http://www.pharmpro.com/articles/2012/05/processing-components-How-To-Read-A-Regulator-Flow-Curve/</link><description>
&lt;p&gt;When selecting a regulator, you are not just looking for the right size. You’re looking for a set of capabilities, which is a function of the regulator’s design. A flow curve illustrates the regulator’s range of capabilities at one glance. Once you understand a flow curve – and we’ll explain how – it is easy and very quick to read.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 18:56:21 GMT</pubDate></item><item><title>A Novel Intradermal Adapter to Address the Growing Use and Demand of Safe, Reliable, and Repeatable Intradermal Delivery of Vaccines</title><link>http://www.pharmpro.com/articles/2012/05-A-Novel-Intradermal-Adapter/</link><description>
&lt;p&gt;&lt;span&gt;Over the past few years, there has been a growing awareness of the unique benefits of delivering vaccines intradermally. Potential benefits include improved vaccine safety, increased vaccine effectiveness, and enhanced immunogenicity in hard to vaccinate populations such as the elderly. &lt;/span&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 17:59:04 GMT</pubDate></item><item><title>Industrial Wireless: Improving the Flexibility of Pharmaceutical Plants</title><link>http://www.pharmpro.com/articles/2012/05-Industrial-Wireless-Improving-the-Flexibility-of-Pharmaceutical-Plants/</link><description>
&lt;p&gt;&lt;span&gt;New technology developments such as industrial wireless are having a profound effect on plant operating strategies. By enabling greater workforce mobility and connectivity, wireless allows manufacturers to diversify production, and change from a single-chain product to producing multi-chain products, in an efficient and flexible way to help meet the needs of patients.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 14:57:57 GMT</pubDate></item><item><title>USP Introduces Useful Guidelines on Sterilization and Contamination Control</title><link>http://www.pharmpro.com/articles/2012/05/agencies-and-organizations-USP-Introduces-Useful-Guidelines-on-Sterilization-and-Contamination-Control/</link><description>
&lt;p&gt;&lt;span&gt;A product recall is problematic for any manufacturer. In the last year alone, recalls of pharmaceutical and health-related products have included baby lotions, parenteral nutrition products, nasal decongestant sprays and alcohol swabs used in preparation for patient injections—all resulting from microbial contamination. &lt;/span&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 14:32:11 GMT</pubDate></item><item><title>Line Performance Optimization - A problem-solving process for pharmaceutical manufacturing</title><link>http://www.pharmpro.com/articles/2012/05/business-Line-Performance-Optimization/</link><description>
&lt;p&gt;Line Performance Optimization&lt;sup&gt;&lt;font size="2"&gt;SM&lt;/font&gt;&lt;/sup&gt; (LPO) integrates best practices in asset management, lean and change management to solve chronic and persistent reliability issues with a specific manufacturing line.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 07 May 2012 12:28:18 GMT</pubDate></item><item><title>QbD and the New Process Validation Guidance</title><link>http://www.pharmpro.com/articles/2012/04/-QbD-and-the-New-Process-Validation-Guidance/</link><description>
&lt;p&gt;Very simply, the aim of pharmaceutical development is to design a quality product and manufacturing process to consistently deliver the intended performance of a final therapeutic product.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Fri, 27 Apr 2012 16:54:52 GMT</pubDate></item><item><title>Continuous Powder Blending</title><link>http://www.pharmpro.com/articles/2012/04-Continuous-Powder-Blending/</link><description>
&lt;p&gt;How to evaluate opportunities for continuous powder blending.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Thu, 26 Apr 2012 15:35:29 GMT</pubDate></item><item><title>Biosimilars and Biobetters</title><link>http://www.pharmpro.com/articles/2012/04-Biosimilars-and-Biobetters/</link><description>
&lt;p&gt;How both are impacting biopharmaceutical manufacturing and CMOs.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Thu, 26 Apr 2012 15:21:54 GMT</pubDate></item><item><title>CMOs and Recalls</title><link>http://www.pharmpro.com/articles/2012/04/outsourcing-news-CMOs-and-Recalls/</link><description>
&lt;p&gt;Don't let your CMO become your weak link in a recall.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Thu, 26 Apr 2012 15:12:26 GMT</pubDate></item><item><title>Singled Out</title><link>http://www.pharmpro.com/articles/2012/04/business-Singled-Out/</link><description>
&lt;p&gt;Single-use technologies help pharmaceutical manufacturers eliminate cross-contamination, but the benefits of disposables can extend far beyond safety.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 25 Apr 2012 14:38:48 GMT</pubDate></item><item><title>Outsourcing Done Right</title><link>http://www.pharmpro.com/articles/2012/04-Outsourcing-Done-Right/</link><description>
&lt;p&gt;Pharma Tech Industries’ vertically Integrated facility offers capacity, expertise and the service to back it all up.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 25 Apr 2012 14:27:12 GMT</pubDate></item><item><title>RFID Technology Improves Product Quality and Process Efficiency for Diverse Pharmaceutical Applications</title><link>http://www.pharmpro.com/articles/2012/04-RFID-Technology-Improves-Product-Quality-and-Process-Efficiency/</link><description>
&lt;p&gt;Today’s fast-paced pharmaceutical manufacturing and processing environments rely on high precision performance to ensure consistent product identification, monitoring and tracking. Further, these products must be verified to be of the highest quality—from manufacturing to delivery.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 24 Apr 2012 17:47:21 GMT</pubDate></item><item><title>A Guide to QbD for APIs</title><link>http://www.pharmpro.com/articles/2012/04/business-A-Guide-to-QbD-for-APIs/</link><description>
&lt;p&gt;In the manufacturing world common sense tells us that producing quality product the first time without interruptions (QbD) is more satisfying compared to the process where we have to stop and examine the progress at intermediate steps (QbA).&lt;/p&gt;
</description>Mike Auerbach<pubDate>Fri, 20 Apr 2012 14:15:23 GMT</pubDate></item><item><title>Process Optimization: Innovation&amp;#39;s Role</title><link>http://www.pharmpro.com/articles/2012/04/business-Process-Optimization-Innovations-Role/</link><description>
&lt;p&gt;Process optimization is a key service for the drug development industry that supports innovation and efficiency in the development, manufacturing and quality assurance of products. Cutting-edge scientific and engineering knowledge are primary attributes that are essential for contract research and manufacturers who are providing this service.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 18 Apr 2012 17:56:57 GMT</pubDate></item><item><title>Tablet Inspection 101</title><link>http://www.pharmpro.com/articles/2012/04-Tablet-Inspection-101/</link><description>
&lt;p&gt;In this article, the author highlights the types of technologies that are available to prevent broken tablets, foreign tablets and softgel capsules as well as foreign material from being packaged.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 17 Apr 2012 15:29:13 GMT</pubDate></item><item><title>The Journey to 2015</title><link>http://www.pharmpro.com/articles/2014/04/packaging-The-Journey-to-2015/</link><description>
&lt;p&gt;The year 2015 is widely considered the beginning of the end for sales of non-serialized drug products. The entire pharmaceutical supply chain will soon undergo a monumental transformation. Yet, despite this pending reality, many decision makers who discuss “2015” continue to do so hypothetically.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 16 Apr 2012 15:12:54 GMT</pubDate></item><item><title>The War On Counterfeiting</title><link>http://www.pharmpro.com/articles/2012/04-The-War-On-Counterfeiting/</link><description>
&lt;p&gt;Counterfeiting - the distribution of imitation goods with the intent to defraud a consumer - is a significant and growing problem for manufacturers, brand owners and consumers alike in wide range of industries.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 09 Apr 2012 20:20:53 GMT</pubDate></item><item><title>Track &amp;amp; Trace Strategies</title><link>http://www.pharmpro.com/articles/2012/04/packaging-Track-and-Trace-Strategies/</link><description>
&lt;p&gt;How to maintain control in a complex and global supply chain.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 09 Apr 2012 12:15:46 GMT</pubDate></item><item><title>Operating Aseptic Facilities</title><link>http://www.pharmpro.com/articles/2012/04/processing-equipment-Operating-Aseptic-Facilities/</link><description>
&lt;p&gt;Bringing online, maintaining, and enhancing any aseptic processing facility presents numerous challenges. By using history as a guide, coupled with an understanding of today’s latest technology and applications, the path to being a more flexible operation in the future becomes much clearer. &lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 02 Apr 2012 16:00:35 GMT</pubDate></item><item><title>CMOs on the Hunt for Disposable Solutions</title><link>http://www.pharmpro.com/articles/2012/04/outsourcing-CMOs-on-the-Hunt-for-Disposable-Solutions/</link><description>
&lt;p&gt;CMOs are constantly looking for technologies that can reduce production and scale-up costs. This year they are finding those answers in single-use technology.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 02 Apr 2012 15:03:40 GMT</pubDate></item><item><title>R&amp;amp;D Renewal</title><link>http://www.pharmpro.com/articles/2012/03/events-R-and-D-renewal/</link><description>
&lt;p&gt;Roche's refurbishing project helps double R&amp;amp;D output and wins 2012 Facility of the Year Award for Operational Excellence.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 28 Mar 2012 19:17:25 GMT</pubDate></item><item><title>Equipped for Success</title><link>http://www.pharmpro.com/articles/2012/03/events-Equipped-for-Success/</link><description>
&lt;p&gt;Rentschler’s flexible facility wins 2012 FOYA award for Equipment Innovation.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 27 Mar 2012 20:08:29 GMT</pubDate></item><item><title>A Walk in the Park</title><link>http://www.pharmpro.com/articles/2012/03/events-A-Walk-in-the-Park/</link><description>
&lt;p&gt;Unique partnerships help NIBRT earn FOYA’s 2012 Special Recognition for Novel Collaboration award.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 27 Mar 2012 18:57:01 GMT</pubDate></item><item><title>Accelerating Production</title><link>http://www.pharmpro.com/articles/2012/03/events-Accelerating-Production/</link><description>
&lt;p&gt;Merck’s modular method helps the company win the 2012 FOYA Award for Facility Integration.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 27 Mar 2012 18:10:58 GMT</pubDate></item><item><title>Expanding Horizons</title><link>http://www.pharmpro.com/articles/2012/03/events-Expanding-Horizons/</link><description>
&lt;p&gt;Eisai's fourth knowledge center wins 2012 Facility of the Year Award for Project Execution.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 27 Mar 2012 15:50:13 GMT</pubDate></item><item><title>High Efficiency</title><link>http://www.pharmpro.com/articles/2012/03/events-high-efficiency/</link><description>
&lt;p&gt;Chiesi's energy efficiency efforts lead to 2012 Facility of the Year Award for Sustainability.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 27 Mar 2012 15:07:29 GMT</pubDate></item><item><title>Engineering the Future</title><link>http://www.pharmpro.com/articles/2012/03/outsourcing-Engineering-the-Future/</link><description>
&lt;p&gt;Engineering firms provide the expertise needed for next generation pharmaceuticals.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 26 Mar 2012 18:46:24 GMT</pubDate></item><item><title>The Biosimilars Challenge</title><link>http://www.pharmpro.com/articles/2012/03-The-Biosimilars-Challenge/</link><description>
&lt;p&gt;The biosimilars market could mean billions in business to contract manufacturers and significant savings for biopharmaceutical patients.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Mon, 26 Mar 2012 18:37:38 GMT</pubDate></item><item><title>The Proof Is in the Packaging</title><link>http://www.pharmpro.com/articles/2012/03/packaging-equipment-The-Proof-Is-in-the-Packaging/</link><description>
&lt;p&gt;Proper packaging procedures can protect the safety of your consumers, subsequently preserving your brand's reputation.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Thu, 22 Mar 2012 18:30:36 GMT</pubDate></item><item><title>Following the Science</title><link>http://www.pharmpro.com/articles/2012/03/pharmaceutical-companies-Following-the-Science/</link><description>
&lt;p&gt;Roche’s potent compound development facility is poised to handle the future&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 21 Mar 2012 18:23:50 GMT</pubDate></item></channel></rss>
